1. Home
  2. PLRX vs BAND Comparison

PLRX vs BAND Comparison

Compare PLRX & BAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLRX
  • BAND
  • Stock Information
  • Founded
  • PLRX 2015
  • BAND 2000
  • Country
  • PLRX United States
  • BAND United States
  • Employees
  • PLRX N/A
  • BAND N/A
  • Industry
  • PLRX Biotechnology: Pharmaceutical Preparations
  • BAND Computer Software: Prepackaged Software
  • Sector
  • PLRX Health Care
  • BAND Technology
  • Exchange
  • PLRX Nasdaq
  • BAND Nasdaq
  • Market Cap
  • PLRX 77.3M
  • BAND 358.3M
  • IPO Year
  • PLRX 2020
  • BAND 2017
  • Fundamental
  • Price
  • PLRX $1.40
  • BAND $15.73
  • Analyst Decision
  • PLRX Hold
  • BAND Buy
  • Analyst Count
  • PLRX 10
  • BAND 6
  • Target Price
  • PLRX $9.79
  • BAND $20.80
  • AVG Volume (30 Days)
  • PLRX 1.6M
  • BAND 252.7K
  • Earning Date
  • PLRX 08-06-2025
  • BAND 07-31-2025
  • Dividend Yield
  • PLRX N/A
  • BAND N/A
  • EPS Growth
  • PLRX N/A
  • BAND N/A
  • EPS
  • PLRX N/A
  • BAND N/A
  • Revenue
  • PLRX N/A
  • BAND $751,695,000.00
  • Revenue This Year
  • PLRX N/A
  • BAND $2.41
  • Revenue Next Year
  • PLRX N/A
  • BAND $13.51
  • P/E Ratio
  • PLRX N/A
  • BAND N/A
  • Revenue Growth
  • PLRX N/A
  • BAND 18.51
  • 52 Week Low
  • PLRX $1.10
  • BAND $11.33
  • 52 Week High
  • PLRX $16.10
  • BAND $23.90
  • Technical
  • Relative Strength Index (RSI)
  • PLRX 54.68
  • BAND 58.66
  • Support Level
  • PLRX $1.13
  • BAND $15.68
  • Resistance Level
  • PLRX $1.27
  • BAND $16.26
  • Average True Range (ATR)
  • PLRX 0.11
  • BAND 0.48
  • MACD
  • PLRX 0.02
  • BAND 0.05
  • Stochastic Oscillator
  • PLRX 90.00
  • BAND 76.12

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

About BAND Bandwidth Inc.

Bandwidth Inc is cloud-based communications platform-as-a-service (CPaaS) provider that enables enterprises to create, scale and operate voice or messaging communications services across any mobile application or connected device. Company earns revenue through the sale of communications services offered through Application Programming Interface software solutions to enterprise customers. The majority of our revenue is generated from usage-based fees that includes voice communication and messaging communication that traverse the platform and network.

Share on Social Networks: